TP53 and cancer: Additionally, it is hypothesized that nearly all cancers have a compromised P53 pathway, as the remaining 50% of cancers that lack TP53 mutations often have mutated genes that lie either up- or downstream of P53 and may also lead to the inactivation of the P53 pathway [15,16].